Clinical Trial Update: A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial investigating allopurinol to prevent kidney function loss in type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetic Nephropathies

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Alessandro Doria | Conditions: Diabetic Nephropathies, Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-11-20